Idiopathic pulmonary arterial hypertension in children

2011 ◽  
pp. 559-571
Author(s):  
Dunbar Ivy
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Idiopathic Pulmonary Arterial Hypertension ◽  
Pulmonary Arterial ◽  
Hypertension In Children

Clinical impact of subcutaneous treprostinil in trisomy 21 patient with pulmonary arterial hypertension associated with CHD

2022 ◽  
pp. 1-3
Author(s):  
Ryusuke Numata ◽  
Kiyohiro Takigiku ◽  
Kouta Takei
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Pulmonary Artery ◽  
Arterial Hypertension ◽  
Exercise Capacity ◽  
Trisomy 21 ◽  
Pulmonary Artery Hypertension ◽  
Idiopathic Pulmonary Arterial Hypertension ◽  
Clinical Impact ◽  
Pulmonary Arterial ◽  
Hypertension In Children

Abstract Subcutaneous treprostinil is commonly used to improve idiopathic pulmonary arterial hypertension in children. However, its effectiveness has not been reported in trisomy 21. We report the case of 9-year-old boy in trisomy 21 with CHD-pulmonary artery hypertension after surgical correction of CHD. Haemodynamics and exercise capacity dramatically improved with a transition from oral selexipag to subcutaneous treprostinil.

CT of the chest in the evaluation of idiopathic pulmonary arterial hypertension in children

2007 ◽  
Vol 37 (4) ◽  
pp. 345-350 ◽  
Author(s):  
Gulraiz Chaudry ◽  
Cathy MacDonald ◽  
Ian Adatia ◽  
Munire Gundogan ◽  
David Manson
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Arterial Hypertension ◽  
Idiopathic Pulmonary Arterial Hypertension ◽  
Pulmonary Arterial ◽  
Hypertension In Children
Sign in / Sign up

Export Citation Format

Share Document